Clinical Trial Update: Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gamma-frequency sensory stimulation (40 Hz light, sound, and related devices) for brain effects in cognitively healthy people …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Massachusetts Institute of Technology | Conditions: Cognitively Healthy People, Alzheimer Disease | Phase 2 | Status: RECRUITING